11th December RNS21 Jan 2019 22:43
"In conjunction with this loan facility and in order to deepen the orphan drug expertise in Venn it has been agreed that certain boad changes will be made, with immediate effect...... a subscriber to £108,642 loan notes (and associated warrants over 657,285 shares); ......a principal of Raglan Capital Limited.....will join the board of Venn"
If you look at the comment I made the day that RNS came out. If you let "a principal of Raglan Capital Limited" onto a board, then this is what will happen. However, we are not done yet. They will take this further down with impunity as they now know all announcements that will be made ahead of the market. As Westminster did with Cannacord. As has been done countless times with AIM companies.
Finance people cannot be allowed to have market sensitive information ahead of the curve. This is what happens.